Dysfunction ICD-10 Code

• N53.8 - Other male sexual dysfunction
• N53.9 - Unspecified male sexual dysfunction
• N52.2 - Drug-induced erectile dysfunction
• N52.8 - Other male erectile dysfunction
• N52.0 - Vasculogenic erectile dysfunction
• H02.88 - Meibomian gland dysfunction of eyelid
• H02.881 - Meibomian gland dysfunction right upper eyelid
• H02.882 - Meibomian gland dysfunction right lower eyelid
• H02.883 - Meibomian gland dysfunction of right eye, unspecified eyelid
• H02.884 - Meibomian gland dysfunction left upper eyelid
• H02.885 - Meibomian gland dysfunction left lower eyelid
• H02.886 - Meibomian gland dysfunction of left eye, unspecified eyelid
• H02.889 - Meibomian gland dysfunction of unspecified eye, unspecified eyelid
• N31.2 - Flaccid neuropathic bladder, not elsewhere classified
• N53.8 - Other male sexual dysfunction
• N53.9 - Unspecified male sexual dysfunction
• N31.8 - Other neuromuscular dysfunction of bladder
• N31.9 - Neuromuscular dysfunction of bladder, unspecified
• N31.1 - Reflex neuropathic bladder, not elsewhere classified
• H02.88A - Meibomian gland dysfunction right eye, upper and lower eyelids
• H02.88B - Meibomian gland dysfunction left eye, upper and lower eyelids
• H83.2 - Labyrinthine dysfunction
• H83.2X - Labyrinthine dysfunction
• H83.2X1 - Labyrinthine dysfunction, right ear
• H83.2X2 - Labyrinthine dysfunction, left ear
• H83.2X9 - Labyrinthine dysfunction, unspecified ear
• G71.033 - Limb girdle muscular dystrophy due to dysferlin dysfunction
• G71.035 - Limb girdle muscular dystrophy due to anoctamin-5 dysfunction
• G71.0341 - Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction
• G71.034 - Limb girdle muscular dystrophy due to sarcoglycan dysfunction
• G71.0340 - Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified
• G71.0349 - Limb girdle muscular dystrophy due to other sarcoglycan dysfunction
• G71.035 - Limb girdle muscular dystrophy due to anoctamin-5 dysfunction
• E23.3 - Hypothalamic dysfunction, not elsewhere classified
• F11.281 - Opioid dependence with opioid-induced sexual dysfunction
• F11.981 - Opioid use, unspecified with opioid-induced sexual dysfunction
• F11.181 - Opioid abuse with opioid-induced sexual dysfunction
• E28.8 - Other ovarian dysfunction
• E31.8 - Other polyglandular dysfunction
• M99.0 - Segmental and somatic dysfunction
• M99.06 - Segmental and somatic dysfunction of lower extremity
• M99.07 - Segmental and somatic dysfunction of upper extremity
• M99.08 - Segmental and somatic dysfunction of rib cage
• F15.281 - Other stimulant dependence with stimulant-induced sexual dysfunction
• F15.981 - Other stimulant use, unspecified with stimulant-induced sexual dysfunction
• F15.181 - Other stimulant abuse with stimulant-induced sexual dysfunction
• E29.8 - Other testicular dysfunction
• N52.37 - Erectile dysfunction following prostate ablative therapy
• N31.0 - Uninhibited neuropathic bladder, not elsewhere classified